Historical record - last NADAC effective date: 5/18/2022

Product Information

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by Epic Pharma LLC, priced at $0.1272 per EA under NDC 42806011201. Its NADAC has been published 210 times since Jun 6, 2018.

FDA first approved this application on Mar 30, 2018. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.1272per EA
DEA Schedule CII

Strength

325; 7.5 mg/1; mg/1

Manufacturer

Epic Pharma LLC

NDC

42806011201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

5/18/2022

Approval Type

Generic (ANDA)

FDA Application

ANDA203863

FDA Approved

3/30/2018

TE Code

AA

On Market Since

4/2/2018

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 210 times since Jun 6, 2018, and over the history we have for it it has declined 6.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1272 per EA
All-time high$0.1449 (Nov 11, 2020)
All-time low$0.0932 (Dec 18, 2019)
Median price$0.1225
Average price$0.1210
Largest weekly change+41.5% (Jan 22, 2020)
Weeks tracked210
Tracking sinceJun 6, 2018

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

+14.5%

All

-6.9%

Last surveyed Jun 8, 2022 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by Epic Pharma LLC, is $0.1272 per EA (NDC 42806011201), effective Jun 8, 2022.

How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has declined 6.9%. It has been tracked across 210 weekly CMS publications since Jun 6, 2018.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

Since Jun 6, 2018, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.0932 (Dec 18, 2019) to a high of $0.1449 (Nov 11, 2020), with a median of $0.1225 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, is $0.1256 per EA — about 1% below HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET.

Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 42806011201) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.